12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

Altus Formulation, Zogenix deal

The companies partnered to develop abuse deterrent formulations of Zogenix's Zohydro ER hydrocodone bitartrate, which was approved by FDA last month to manage chronic pain severe enough to require a continuous, around-the-clock opioid...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >